Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-EN Version v6-FR
Language English French
Date Updated 2021-03-12 2020-10-02
Drug Identification Number 02403269 02403269
Brand name JENTADUETO JENTADUETO
Common or Proper name Jentadueto 2.5/850mg 6x10 Jentadueto 2.5/850mg 6x10
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients LINAGLIPTIN METFORMIN HYDROCHLORIDE LINAGLIPTIN METFORMIN HYDROCHLORIDE
Strength(s) 2.5MG 850MG 2.5MG 850MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Blister Pack 6x10 Blister Pack 6x10
ATC code A10BD A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-10-05 2020-10-05
Actual start date 2020-10-05
Estimated end date 2021-03-12 2020-11-06
Actual end date 2021-03-11
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments